Avadel Pharmaceuticals Plc (AVDL)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AVDL? Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile

Avadel Pharmaceuticals Plc

Healthcare (1176)

636-449-1830

BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN

@AvadelPharma

Nächster Verdiensttermin

Neueste SEC-Einreichungen

AVDL's Discussions on Twitter

Vergleichen Sie AVDL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AVDL Avadel Pharmaceuticals Plc	7.90	761.26M	47.56M	-156.83M	-127.98M	-1.83
ZTS Zoetis Inc	167.53	75.58B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.24	41.78B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.10	41.53B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	21.82	24.72B	16.77B	-959.00M	1.37B	-0.85
NBIX Neurocrine Biosciences Inc	145.88	14.77B	2.24B	385.90M	440.10M	3.73

Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-06-12	Eingeleitet	Rodman & Renshaw	Buy
2024-03-05	Bestätigt	H.C. Wainwright	Buy
2024-03-05	Bestätigt	Needham	Buy
2024-03-05	Bestätigt	Oppenheimer	Outperform
2024-02-06	Eingeleitet	UBS	Buy
2022-11-30	Hochstufung	Jefferies	Hold → Buy
2022-08-10	Herabstufung	Jefferies	Buy → Hold
2022-07-28	Fortgesetzt	Craig Hallum	Buy
2022-05-26	Herabstufung	Stifel	Buy → Hold
2021-09-23	Eingeleitet	Needham	Buy
2020-07-31	Eingeleitet	Oppenheimer	Outperform
2020-07-21	Eingeleitet	SVB Leerink	Outperform
2020-06-30	Eingeleitet	H.C. Wainwright	Buy
2020-04-03	Eingeleitet	Jefferies	Buy
2020-03-12	Eingeleitet	Stifel	Buy
2020-02-26	Eingeleitet	Piper Sandler	Overweight
2020-01-30	Eingeleitet	Craig Hallum	Buy
2019-06-14	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2019-02-08	Herabstufung	Ladenburg Thalmann	Buy → Neutral

Alle ansehen

Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten

Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)

Avadel Pharmaceuticals Plc (AVDL)

Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile

Vergleichen Sie AVDL mit anderen Aktien

Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades

Avadel Pharmaceuticals Plc Aktie (AVDL) Neueste Nachrichten

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of "Buy" by Analysts - MarketBeat

There May Still Be Time to Get in on These 3 Trending Biotechs - MarketBeat

Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up Following Insider Buying Activity - MarketBeat

Avadel Pharmaceuticals director Peter Thornton buys shares worth $80,450 By Investing.com - Investing.com Australia

Avadel Pharmaceuticals director Peter Thornton buys shares worth $80,450 - Investing.com India

Insider Buying: Peter Thornton Acquires 10,000 Shares of Avadel Pharmaceuticals PLC - GuruFocus.com

Peter J. Thornton Purchases 10,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) Stock - MarketBeat

Avadel Pharmaceuticals director Eric Ende buys $235,218 in shares By Investing.com - Investing.com South Africa

Avadel Pharmaceuticals director Eric Ende buys $235,218 in shares - Investing.com

Avadel Pharmaceuticals (NASDAQ:AVDL) Given New $14.00 Price Target at UBS Group - MarketBeat

What is Lifesci Capital's Forecast for AVDL FY2024 Earnings? - MarketBeat

Avadel Pharmaceuticals: Patient Attrition Weighs On 2025 Outlook (NASDAQ:AVDL) - Seeking Alpha

Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target Lowered to $13.00 at Piper Sandler - MarketBeat

Avadel Pharmaceuticals (NASDAQ:AVDL) Hits New 52-Week Low After Analyst Downgrade - MarketBeat

Avadel Pharmaceuticals (NASDAQ:AVDL) Earns Buy Rating from HC Wainwright - MarketBeat

Avadel reports strong Q4 growth for narcolepsy drug LUMRYZ By Investing.com - Investing.com Australia

Avadel Pharmaceuticals (NASDAQ:AVDL) Price Target Cut to $19.00 by Analysts at Needham & Company LLC - MarketBeat

Avadel Pharmaceuticals plc Provides Update on Revitalyz Pivotal Study - Marketscreener.com

Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ - Benzinga

Avadel announces preliminary Q4 net product revenue of $50 million - MSN

AVDLAvadel Pharmaceuticals plc Ordinary Share Latest Stock News & Market Updates - StockTitan

After-hours movers: NVIDIA, Costco, Penguin Solutions, Avadel Pharma By Investing.com - Investing.com Nigeria

Avadel reports strong Q4 growth for narcolepsy drug LUMRYZ - Investing.com

Avadel Pharmaceuticals Projects Robust Growth for LUMRYZ - TipRanks

Avadel Pharmaceuticals falls as Q4 revenue misses estimates; shares sink 20% - Investing.com Nigeria

Avadel Pharmaceuticals falls as Q4 revenue misses estimates; shares sink 20% By Investing.com - Investing.com South Africa

Avadel Announces Preliminary 2024 Results and 2025 Commercial Priorities to Accelerate the LUMRYZ Launch - The Manila Times

Avadel's LUMRYZ Narcolepsy Drug Hits $50M in Q4, Patient Base Surges 275% as Growth Accelerates - StockTitan

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Previe - GuruFocus.com

Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Avadel Pharmaceuticals Grants Stock Options to 12 New Employees in Strategic Talent Expansion - StockTitan

Avadel Pharmaceuticals to Provide a Corporate Update and Preliminary Fourth Quarter and Full Year 2024 Financial Highlights on January 8 - The Manila Times

Avadel Pharmaceuticals Schedules Q4 & Full Year 2024 Financial Results Conference Call - StockTitan

Geode Capital Management LLC Has $15.14 Million Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Stifel Financial Corp Sells 1,452 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives $24.43 Consensus Price Target from Analysts - MarketBeat

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of “Buy” by Analysts - Defense World

Fmr LLC Makes New $31,000 Investment in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Purchased by State Street Corp - Defense World

State Street Corp Raises Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat

How the (AVDL) price action is used to our Advantage - Stock Traders Daily

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $484,000 Investment in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World

Barclays PLC Buys 123,430 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat

C-Suite Buy of the Week: Unusual Insider Trading Trends as 2025 Approaches - Benzinga

Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Purchased by Lord Abbett & CO. LLC - MarketBeat

Finanzdaten der Avadel Pharmaceuticals Plc-Aktie (AVDL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie AVDL